NW-G01

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
NW-G01, produced by Streptomyces alboflavus 313, is a novel cyclic hexapeptide antibiotic with many potential applications… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
In the previous paper,1 we described the novel cyclic hexapeptide antibiotic, NW-G01, produced by Streptomyces alboflavus 313. It… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 5
Is this relevant?
2011
2011
NW-G01, a cyclic hexapeptide antibiotic, and 34-epi-NW-G01 were synthesized by the highly stereoselective convergent approach for… (More)
  • figure 1
Is this relevant?
2010
2010
Correction to: The Journal of Antibiotics (2010) 63, 231–235; doi:10.1038/ja.2010.24 The authors of the above article noted some… (More)
  • figure 1
Is this relevant?
2010
2010
NW-G01 is a novel cyclic hexapeptide antibiotic produced by Streptomyces alboflavus 313. Its relative structure was established… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
NW-G01, a novel cyclic hexadepsipeptide antibiotic, was isolated by macroporous resin and silica gel column chromatography and… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?